While the deal between Atlanta-based Aveanna and Maryland-based Maxim won't go forward, the fact that it drew FTC's attention shows how closely the agency is watching for consolidation issues in the marketplace.
from Kaiser Health News https://ift.tt/2RQD3Bs
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment